Sartorius Ag (SARTF) – Investment Analysts’ Recent Ratings Changes

A number of research firms have changed their ratings and price targets for Sartorius Ag (NASDAQ: SARTF):

  • 9/19/2017 – Sartorius Ag was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $106.00 price target on the stock. According to Zacks, “Sartorius AG is a pharmaceutical and laboratory equipment supplier. The company manufactures equipment for biomolecular and microbial separations, cell culture, concentration, fermentation and purification. Sartorius AG is headquartered in Goettingen, Germany. “
  • 9/16/2017 – Sartorius Ag was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Sartorius AG is a pharmaceutical and laboratory equipment supplier. The company manufactures equipment for biomolecular and microbial separations, cell culture, concentration, fermentation and purification. Sartorius AG is headquartered in Goettingen, Germany. “
  • 9/12/2017 – Sartorius Ag was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $106.00 price target on the stock. According to Zacks, “Sartorius AG is a pharmaceutical and laboratory equipment supplier. The company manufactures equipment for biomolecular and microbial separations, cell culture, concentration, fermentation and purification. Sartorius AG is headquartered in Goettingen, Germany. “
  • 9/9/2017 – Sartorius Ag was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Sartorius AG is a pharmaceutical and laboratory equipment supplier. The company manufactures equipment for biomolecular and microbial separations, cell culture, concentration, fermentation and purification. Sartorius AG is headquartered in Goettingen, Germany. “
  • 8/16/2017 – Sartorius Ag was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $100.00 price target on the stock. According to Zacks, “Sartorius AG is a pharmaceutical and laboratory equipment supplier. The company manufactures equipment for biomolecular and microbial separations, cell culture, concentration, fermentation and purification. Sartorius AG is headquartered in Goettingen, Germany. “
  • 8/15/2017 – Sartorius Ag was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Sartorius AG is a pharmaceutical and laboratory equipment supplier. The company manufactures equipment for biomolecular and microbial separations, cell culture, concentration, fermentation and purification. Sartorius AG is headquartered in Goettingen, Germany. “
  • 7/27/2017 – Sartorius Ag was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $101.00 price target on the stock. According to Zacks, “Sartorius AG is a pharmaceutical and laboratory equipment supplier. The company manufactures equipment for biomolecular and microbial separations, cell culture, concentration, fermentation and purification. Sartorius AG is headquartered in Goettingen, Germany. “

Sartorius Ag (SARTF) opened at 96.00 on Thursday. The stock has a market cap of $6.57 billion and a price-to-earnings ratio of 53.30. Sartorius Ag has a one year low of $75.00 and a one year high of $96.00.

Receive News & Ratings for Sartorius Ag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius Ag and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply